These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27216900)

  • 1. Redefining Medication Adherence in the Treatment of Schizophrenia: How Current Approaches to Adherence Lead to Misinformation and Threaten Therapeutic Relationships.
    Weiden PJ
    Psychiatr Clin North Am; 2016 Jun; 39(2):199-216. PubMed ID: 27216900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication Adherence Decisions in Patients With Schizophrenia.
    Kikkert MJ; Dekker J
    Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplifying adherence in schizophrenia.
    Hardeman SM; Harding RK; Narasimhan M
    Psychiatr Serv; 2010 Apr; 61(4):405-8. PubMed ID: 20360281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
    Jaeger S; Weißhaupt S; Flammer E; Steinert T
    Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compliance].
    Vandel P
    Encephale; 2007 Jun; 33 Pt 3():S399-401. PubMed ID: 19101359
    [No Abstract]   [Full Text] [Related]  

  • 12. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
    Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adherence to neuroleptic treatment of schizophrenic patients].
    Blondiaux I; Alagille M; Ginestet D
    Encephale; 1988; 14(6):431-8. PubMed ID: 2906607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Affecting Medication Adherence Among Adults with Schizophrenia: A Literature Review.
    Tham XC; Xie H; Chng CM; Seah XY; Lopez V; Klainin-Yobas P
    Arch Psychiatr Nurs; 2016 Dec; 30(6):797-809. PubMed ID: 27888977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denial and acceptance coping styles and medication adherence in schizophrenia.
    Aldebot S; de Mamani AG
    J Nerv Ment Dis; 2009 Aug; 197(8):580-4. PubMed ID: 19684494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.